维普中文期刊产品整合服务
16篇 您的检索式:作者名="Fanale MA"
    题名 作者 年代 出处 被引量
1A phase Iweekly dosing study of brentuximab vedotin in patients withrelapsed/refractory CD30-positive hematologic malignancies 显示文摘Fanale MA Forero-Torres A Rosenblatt JD 2012Clin Cancer Res2012,18,:1
2A phase I weekly dosing study of brentuximab vedotin in patients with re- lapsed/refractory CD30-positive hematologic malignancies 显示文摘Fanale MA Forero-Torres A Rosenblatt JD 2012Clin Cancer Res2012,18,1:1
3A phase I week- ly dosing study of brentuximab vedotin in patients with relapsed/ refractory CD30-positive hematologic malignancies显示文摘Fanale MA Forero-Torres A Rosenblatt JD 2012Clin Can- cer Res2012,18,1:1
4A randomizedtrial of a single-dose rasburicase versus five-daily doses inpatients at risk for tumor lysis syndrome 显示文摘Vadhan-Raj S Fay ad LE Fanale MA 2012Ann Oncol2012,23,6:1
5Retreatment with brentux- imab vedotin in patients with CD30-positive hematologic malig- nancies显示文摘Bartlett NL Chen R Fanale MA 2014J Hematol Oncol2014,7,1:1
6Phase I study of bortezomib plus ICE(BICE)for the treatment of relapsed/refractory Hodgkin lymphoma显示文摘Fanale MA Fayad LE Pro B 2011Br J Heamotol2011,153,:1
7Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy显示文摘Fanale MA Uyei AR Theriault RL 2005Clin Breast Cancer2005,6,4:1
8Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies显示文摘Bartlett NL Chen R Fanale MA 2014J Hematol Oncol2014,7,:1
9A phase I study of bortezomib in combination with ICE(BICE)in patients with relapse/refractory classical Hodgkin's lymphoma显示文摘Fanale MA Fayad LE Pro B 2008Blood2008,112,:1
10Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma 显示文摘FANALE MA YOUNES A 2007Drugs2007,67,3:1
11Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-typep53显示文摘Pataer A Fanale MA Roth A 0,,8:1
12Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma显示文摘Fanale MA Younes A 2007Drugs2007,67,3:1
13Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type P53显示文摘Pataer A Fanale MA Roth JA 2006Cancer Gene Ther2006,13,8:1
14Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma显示文摘Fanale MA Younes A 2007Drugs2007,67,3:1
15Brentuximab vedotin in the front-line treatment of patients with CD30 + peripheral T-cell lymphomas : results of a phase I study 显示文摘Fanale MA Horwitz SM Forero-Torres A 2014J Clin Oncol2014,32,28:1
16Retreatment with in patients with CD30-positive hematologic malignancies显示文摘BARTLETr NL CHEN R FANALE MA 2014J HematolOncol2014,7,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费